The grant allows a team to spend the next three years trying to unlock the blood brain barrier to allow drugs to be targeted at diseases including cancer. The £451,000 grant was given by the Biotechnology and Biological Sciences Research Council.
Drugs already exist that can be successfully used against some diseases elsewhere in the body but when those diseases are in the brain they are much harder to treat because most drugs cannot penetrate the protective barrier.
Dr Eugen Barbu, a chemist, will lead a team of four scientists from the School of Pharmacy aiming to modify a natural polymer so it can temporarily create an opening in the blood brain barrier and get through to deliver medicine. They will use polymer-based nanoparticles that are approximately 1/1000 of the diameter of a single human hair, which is about 80,000 nanometres wide.
The modified polymer would be small enough to breach the blood brain barrier and would act like a delivery container carrying the drug. Once they deliver their drug load to the brain they would biodegrade. A novel living 3D cell culture model of the human blood-brain barrier will be used to initially screen the interaction between the nanoparticles and the brain.
The research team chose to study natural polymers because they make excellent drug-carriers, are non-toxic and are biodegradable and biocompatible, so the brain won’t reject them.
Prof Darek Gorecki will be working alongside Dr Barbu. He said: “The BBSRC thought it was worth investing half a million pounds because though other scientists are studying ways of penetrating the blood brain barrier this idea of using modified natural polymers is novel.
“It is very experimental at this stage and the distance from here to doctors being able to better treat brain tumours is a long way off.
“The brain relies upon a rich blood supply but the barrier exists because it is vital not everything in the blood can get through. It is a very sophisticated filter. We are hoping that by using modified polymers working in various ways we can generate a temporary opening in the cells of the blood brain barrier and allow drugs to be delivered straight to the brain.”
If successful, the temporary unlocking of the filter would allow a range of brain diseases to be treated more efficiently. It is hoped that in the long term these formulations will be useful for the treatment of a range of brain diseases including brain tumours, stroke and neurodegenerative disorders.
The research group comprises a multidisciplinary team of Dr Barbu, senior research fellow, Dr John Tsibouklis, reader in polymer science, Professor Geoffrey Pilkington, a professor of cellular and molecular neuro-oncology and world-renowned expert in brain tumour biology and pathology, and Prof Gorecki, professor of molecular medicine. The team work in the Institute of Biomedical and Biomolecular Science, Biomaterials and Bionanotechnology and Cellular and Molecular Medicine Groups at the university, and will be supported by two post-doctoral researchers.
Kate Daniell | alfa
New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia
New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
18.08.2017 | Life Sciences
18.08.2017 | Physics and Astronomy
18.08.2017 | Materials Sciences